Aurobindo Pharma has informed that the Nomination and Remuneration/Compensation Committee of the Company on March 09, 2016 has allotted 3,50,036 equity shares of Re 1 each under ESOP Scheme of the Company. Consequent to the allotment, the paid up share capital of the Company has increased from 58,48,19,550 Equity Shares of Re 1 each to 58,51,69,586 Equity Shares of Re 1 each.
The above information is a part of company’s filings submitted to BSE.